NCT03205878

Brief Summary

Patients with obstructive sleep apnea (OSA) are less physically active than healthy controls. First choice of treatment for OSA is continuous positive airway pressure (CPAP) therapy with an improvement in oxygen saturation and sleep. No improvement on physical activity has been shown. The current study would randomize patients in a standard care group (CPAP) and an intervention group (CPAP + telecoaching). Telecoaching will be performed for 3 months, with physical activity assessment before, after 3 months and 12 years.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2017

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 28, 2017

Completed
3 days until next milestone

Study Start

First participant enrolled

July 1, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 2, 2017

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

July 2, 2017

Status Verified

June 1, 2017

Enrollment Period

2.5 years

First QC Date

June 28, 2017

Last Update Submit

June 29, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in steps per day after 3 months

    Steps per day as measured by a step counter

    The change will be measured after 3 months

Secondary Outcomes (9)

  • The proportion of patients with an increase > 1,000 steps per day

    After 3 months (end of telecoaching) and after 12 months

  • The proportion of patients with > 7500 steps/day

    Before initiation of telecoaching (baseline), after 3 months (end of telecoaching) and after 12 months

  • Change in functional exercise capacity

    3 months and 12 months compared with baseline

  • Change in daytime sleepiness

    3 months and 12 months compared with baseline

  • Change in sleep quality

    3 months and 12 months compared with baseline

  • +4 more secondary outcomes

Study Arms (2)

Control group

ACTIVE COMPARATOR

Patients will receive standard care, being CPAP treatment

Device: CPAP

Intervention group

EXPERIMENTAL

Patients will receive CPAP and telecoaching

Other: TelecoachingDevice: CPAP

Interventions

Patients in the intervention arm will receive a step counter and a cell phone with an app on which the amount of steps are daily sent to. Initial targets on steps per day will be discussed with the patient after an activity monitoring before the telecoaching procedure. Dependent whether the patient reaches his/her proposed goal each week, new goals are set.

Intervention group
CPAPDEVICE

Patients will receive CPAP according to standard care

Control groupIntervention group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • AHI \> 15 events/hour, measured by polysomnography
  • \< 7,500 steps per day
  • Willing to start CPAP treatment
  • Age between 18 and 65 years
  • Signing the written informed consent

You may not qualify if:

  • Patients with neuromuscular diseases
  • Patients with chronic obstructive pulmonary disease and interstitial lung disease
  • Patients with cardiac failure and ischemic heart failure
  • Patients with comorbidities which could interfere with a normal biomechanical gait pattern and the possibility of increasing physical activity
  • Patients with mental disability making it impossible to understand the study protocol and the use of electronic devices.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Motor ActivitySleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

BehaviorSleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2017

First Posted

July 2, 2017

Study Start

July 1, 2017

Primary Completion

December 31, 2019

Study Completion

December 31, 2019

Last Updated

July 2, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will not share